Hey Doc – I think I Have Exocrine Pancreatic Insufficiency!

Have you ever noticed how Big Pharma in the United States has things exactly backwards? Instead of developing new pills that people need like non-addictive painkillers and antibiotics for resistant infections, it develops new diseases.

Who remembers Restless Legs Syndrome? It sounded ridiculous but Big Pharma made a lot of money with drugs to treat it. Who remembers Shift Work Sleep Disorder and Non-24-hour Sleep Wake Disorder? Sleep disorders are lucrative for Big Pharma because everyone sleeps – or watches TV when they can’t.

Whenever a reporter writes about such highly-advertised rare diseases they get veritable hate mail. “How dare you imply that Can’t-Wake-Up-in-the-Morning disease doesn’t exist? I have suffered for years!” they scream as they threaten us and our editors and claim we are trying to take their drugs away. “I have adult ADHD no one can tell me I don’t!”

Okay, we tell them – we are sure you have whatever you have. The point we are making is information about diseases should not come from companies who stand to make money from the diseases growing. There should not be symptom quizzes to encourage your suspicion that you have the advertised disease created by the people who make money on it.

epi

You should not be telling a doctor the disease you have and the drug you need – it should be the other way around. Which is the party who went to medical school? Ads for proton therapy even encourage patients to tell their doctor what kind of radiation they need.

What?

Direct to consumer advertising in the United States has galvanized a lot of people who, for one reason or another, like to have a health problem or condition. For example, problems with money, jobs, family, marriage, mood, self-esteem and body image used to be called “life.” Now, they are called “depression” and almost a quarter of the U.S. population is treated for it.

The very fact that a drug is advertised on TV means it is an expensive brand name drug. When people decide they need it rather than a cheaper drug or no drug at all – hello? – everyone’s health care costs go up. Also, the real risks of new drugs advertised on TV are not known because they have not been widely used yet. Many of the drugs withdrawn from the market for safety reasons were highly advertised, blockbuster drugs until they were in wide use.

This fall, North Chicago-based AbbVie rolled out another disease people may have never heard of, but might have. The disease is exocrine pancreatic insufficiency (EPI) and its symptoms include frequent diarrhea, gas and bloating and stomach pain according to the website Identify EPI. AbbVie’s drug, Creon can treat EPI but it also “may increase your chance of having a rare bowel disorder called fibrosing colonopathy” and may cause “frequent or abnormal bowel movements; bloating.” Sounds like you’ll have problems with or without the drug – but with the drug Big Pharma will make money.

Don’t be embarrassed to tell your doctor about your “poop” say awareness ads for EPI. Seems like Big Pharma should be embarrassed for selling diseases to move its medicines.

My cartoon-filled book, Born with a Junk Food Deficiency, explores more sales tactics of Big Pharma and the food industry. It makes a great holiday gift for health-conscious people on your list.

Hot this week

Did David Wineland and Serge Haroche Steal Idea For The Nobel Physics Prize?

Dr. Omerbashich says the Royal Swedish Academy is a Crime Scene and he has the proof that Nobel laureates stole his discovery.

New Approaches to Disaster Relief Challenges

Disaster relief has always been a challenge. NASA, Google,...

3 Legitimate Money Making Methods to Supplement Your Income

In a perfect world, when your landlord raises your...

2016 Predictions by World Renowned Medium and Psychic Lindy Baker

World renowned medium and psychic Lindy Baker is interviewed by The Hollywood Sentinel, discussing psychic power, the spirit world, life after death, areas of concern in 2016, and much more.

Digital Coupon Customers Spending More Than Double At Stores

A new study shows that customers who use digital coupons go shopping more for groceries and other household goods more often and spend more on their shopping trips.

Israel, You Must Muster Unity

But what makes Israel particularly remarkable is the idea that unity does not require sameness.

Choosing The Best Corporate Gifts This Holiday Gifting Season

As the fourth quarter winds down, businesses have a valuable opportunity to express genuine appreciation to the partners, vendors, and customers who fueled their success throughout the year. While branded pens and generic desk accessories o

Islo Raises $15 Million to Address the Next Bottleneck in AI-Powered Software Development

Artificial intelligence is changing the economics of software development,...

Israel Film Festival: 38 Years of Israeli Cinema

Lights, camera, Israel! The 38th Israel Film Festival (IFF) returns to Los Angeles, California, November 18–24, 2026!

Factors to Consider When Looking for the Best Platforms for Trading Synthetic Assets

Choosing one of the best platforms for trading synthetic assets is a crucial decision for a trader interested in synthetic indices. The trading platform or broker you choose will play an integral role in your success as a trader. There are

The Research Document That Changed Meaning in Translation: Why Bilingual Scientific Suppliers Need One Verifiable Record Across Languages

A scientific document can remain visually identical while its meaning changes significantly in translation. A laboratory report may contain the same tables, analytical figures, dates and identifiers in two languages, yet a small difference

The Peptide Study Looked Convincing Until Researchers Asked What It Actually Proved: How Laboratory Findings Become Misleading Human Health Claims

A laboratory experiment produces an impressive result. Researchers observe a measurable biological response after exposing cells to a synthetic peptide. The findings appear in a scientific paper, attract attention online, and eventually bec

Spotlight on M/Y Serdal, a 26m De Birs yacht for sale in Dubai

Serdal offers potential owners something a mere listing can’t, namely the chance to charter her before making an offer. Try before you buy, if you will, this 26-metre superyacht, built by Egyptian shipyard De Birs and delivered to her origi

Related Articles

Popular Categories